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Abstract  
BACKGROUND: Cadmium (Cd) is used in many industries. High-level exposure is associated with 
severe kidney and bone damage.  
AIM: This study investigates the possible effect of occupational cadmium exposure on parathyroid 
gland and some minerals in workers. 
METHODS: Environmental air monitoring of cadmium was done. Serum and urine cadmium levels, 
kidney function, some minerals, and plasma parathormone were estimated in the studied groups.  
RESULTS: The exposed workers had significantly higher Cd concentration in serum and urine than 
controls. The mean levels of plasma parathyroid hormone, serum phosphorus and magnesium 
were significantly lower among the exposed group. However, the mean levels of serum creatinine 
and calcium were significantly higher in the same group when compared to referents. There was a 
significant positive correlation between Cd concentration in the serum and urine for the exposed 
group. The biological Cd exposure indices correlated positively with serum calcium and negatively 
with plasma PTH level. The prevalence of musculoskeletal complaints, bone ache, joint pain and 
muscle spasm were more prevalent among the exposed workers compared with the controls with 
odds ratio 4.316, 3.053 and 3.103 respectively. 
CONCLUSIONS: Occupational cadmium exposure has an adverse effect on PTH level and serum 
human minerals. 
 
 
 
 
Introduction 
 
Cadmium (Cd) is a heavy metal used in the 
fabrication of batteries, as a color pigment, and as an 
anticorrosive agent. Normal people can be exposed to 
Cd through contaminated air, food, and water. Also, 
smoking is another environmental source of Cd [1].  
Cadmium resorption occurs through 
gastrointestinal tract, pulmonary system and skin. The 
kidney is the main organ for long-term cadmium 
accumulation.  
Liver and kidney can change cadmium to a 
harmless form but too much cadmium can overload 
their ability to change it [2]. 
Bone remodeling cycle is a normal process by 
which bone is continually repaired and renewed. 
Osteoporosis develops when there is an imbalance 
between bone formation and bone resorption. 
Osteoporosis is characterized by low bone mass with 
an increase in bone fragility and susceptibility to 
fracture [3]. 
Several studies found that exposure to low 
concentrations of Cd affects bone mineral density 
(BMD)
 
which may increase the risk to osteoporosis 
and fractures [4]. Exposure to cadmium may reduce 
the amount of active form of vitamin D (1, 25(OH)2D) 
produced in the kidney. This delays calcium uptake in 
the duodenum and active calcium reabsorption in the 
distal convoluted tubule which is the main mechanism 
of osteoporosis [5]. Moreover, Cd may affect directly 
osteoblast and osteoclast functions diminishing their 
ability to mineralize and collagen production [6].  
Chronic exposure to Cd affects the structure 
and function of the parathyroids in male rats. The 
effects occur at low Cd accumulation and potentiate 
with the intensity and duration of exposure and body 
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burden of Cd [7]. Cd occupational exposure has for 
long been associated with hypercalciuria, renal tubular 
cell dysfunction and osteoporosis [3].  
Bone effects of occupational Cd exposure in 
apparently healthy men is unclear, therefore, this 
study was performed to investigate the possible effect 
of occupational cadmium exposure on parathyroid 
gland and some minerals among a group of workers 
occupationally exposed to Cd which may give an idea 
about the changes associated with such exposure. 
 
 
Materials and Methods 
 
Subjects 
This is a cross-sectional comparative study 
that included 51 electroplating male non-smoker 
workers exposed to cadmium from a factory in the 
industrial city El-Sadat, Menofia governate in Egypt 
with a mean age 37.6 ± 9.2 yr. and duration of 
exposure ranged between 10-28 yr (15.95 ± 6.9). A 
control group of 43 male nonsmoker employees 
matched for age (36.9 ± 7.5 yr) and social class with 
no past or present history of occupational exposure to 
Cd was included. Subjects having renal problems, 
diabetics, using calcium supplements or vitamin D 
therapy were excluded from this work. The subjects 
investigated did not use any personal protective 
equipment.  
From all participants, a written consent was 
obtained after the nature of the study has been 
explained in full detail. Also, they were interviewed 
and completed a questionnaire that included personal 
data, detailed occupational history (past and present), 
musculoskeletal complaints and medical history. 
 
Sampling 
Venous blood samples were collected with 5 
ml syringes and divided into 2 parts, one part 
collected as clotted blood and centrifuged to separate 
serum to estimate urea, creatinine (Cr), albumin, 
calcium, phosphorus, alkaline phosphatase (ALP), 
and magnesium (Mg). The other part of blood sample 
was collected on an anticoagulant EDTA and 
centrifuged to separate plasma to estimate PTH. The 
serum and plasma samples were immediately frozen 
at –20
o
 C until analyzed. Urine specimens were 
collected in plastic containers previously acid washed 
by 1M HNO3. Also, the urine was frozen and kept at –
20
 o
C until analyzed. 
 
Monitoring 
a) Environmental monitoring: at selected 
workplaces, dust measurements were carried 
out by air sampling from breathing zones. 
Determination of Cd in dust samples was 
carried out by graphite furnace atomic 
absorption spectrometry. 
b) Biological monitoring: for both exposed and 
referent groups: 
Urine samples were analyzed for Cd and Cr. 
Cadmium concentration in urine was determined by 
graphite furnace atomic absorption spectrometry [8].
 
The standard addition technique was used for 
calibration. The cadmium content of urine was 
expressed as micrograms per gram Cr (µg/g Cr) 
excretion to compensate for an effect of muscle mass 
on Cr excretion. 
- Serum Cd concentration was determined by 
graphite furnace atomic absorption spectrometry [8]. 
- Serum urea was determined by urease 
modified Berthelot reaction [9]. 
- Serum and urine creatinine were determined 
by Jaffe method without deproteinization [10]. 
- Serum albumin was determined according to 
Doumans et al [11]. 
- Serum calcium was determined by 
spectrophotometric method [12]. 
- Serum phosphorus was determined 
according to Goodmin [13]. 
- Serum alkaline phosphatase was 
determined according to Belfield and Goldberg [14]. 
- Serum magnesium was determined 
according to Vassault et al [15]. 
- Plasma PTH was determined by ELISA 
according to Endres et al [16]. 
 
Statistical analysis 
The data was statistically analyzed using the 
SPSS18 program. Independent t-test and Chi-square 
test were used to detect the statistical differences in 
the quantitative and qualitative data respectively 
between the two groups. Pearson’s bivariate 
correlation coefficient was also calculated. The 
differences were considered significant at a level of p 
< 0.05. 
 
 
Results 
The time-weighted average concentration of 
Cd in the air was estimated during normal work. The 
air cadmium level ranged from 21 to 26 μg/m
3
 with a 
mean level of 23 ± 0.002 μg/m
3
.
  
There was no significant difference between 
the exposed and the control groups as regards their 
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age (p>0.05). 
Mean levels of Cd in both serum and urine 
were much higher in the exposed group compared to 
the controls and the differences were highly 
statistically significant (p < 0.01) as shown in Table 1.  
Table1: Blood and urinary cadmium concentrations in the 
exposed and referents groups 
 Parameters Exposed (51) Control(43) P-value 
Serum Cd (µg/ dL) 
Urine Cd (µg/g Cr) 
  3.09 ± 1.8 
  9.36 ± 2.43 
0.84 ± 0.19 
1.98 ± 0.54 
<0.001 
<0.001 
 
It was observed from Table 2 that the mean 
levels of serum Cr and calcium were significantly 
higher in the exposed workers than in the controls. 
While, the mean values of plasma PTH, serum 
phosphorus, and Mg were significantly lower in the 
exposed group than in the referent group. There was 
no significant difference between both groups as 
regards serum urea, albumin, and ALP. 
Table 2: Different biochemical variables of studied groups 
Parameters Normal range Exposed (51) Control (43) P-value 
Serum urea (mg/dl) 
Serum Cr (mg/dl) 
Serum albumin (gm/dl) 
Plasma PTH (pg/ml) 
Serum calcium (mg/dl) 
Serum phosphrous (mg/dl) 
Serum ALP (U/ dl) 
Serum Mg (mg/dl) 
10-50 
0.8-1.2 
3.5-5.2 
10-65 
8.5-10.5 
2.5 - 4.5 
3 - 13 
1.8 - 2.6 
34.1 ± 9.6 
1.10 ± 0.16 
4.11 ± 0.3 
33.1 ± 7.1 
10.24 ± 1.48 
2.11 ± 0.74 
9.72 ± 1.67 
1.56 ± 0.37 
32.1 ± 5.66 
0.82 ± 0.11 
4.3 ± 0.5 
51.1 ± 10.4 
9.34 ± 0.71 
3.61 ± 0.79 
12.03 ± 1.86 
2.30 ± 0.29 
>0.05 
<0.001 
>0.05 
<0.001 
<0.001 
<0.001 
>0.05 
<0.001 
 
The prevalence of musculoskeletal complaints 
(Table 3), bone ache, joint pain and muscle spasm 
were more prevalent among the exposed workers 
compared with the controls (p < 0.05) with odds ratio 
4.316, 3.053 and 3.103 respectively. 
Table 3:  Musculoskeletal complaints among the studied 
groups 
Complaints Exposed (51) 
No          % 
Control(43) 
No           % 
χ
2
 95% CI Odds 
Ratio Lower 
limit 
Upper 
limit 
Bone ache 
Joint pain 
Muscle spasm 
Fractures                 
21        37.7 
19        34.0 
23        39.6 
3          5.9 
6           17.0 
7           14.6 
9           19.5 
2             4.2 
<0.007 
<0.041 
<0.024 
>0.050 
1.545 
1.136 
1.238 
12.057 
8.208 
7.776 
4.316 
3.053 
3.103 
 
The correlation between biological Cd 
exposure indices (serum and urinary Cd levels) and 
the other biochemical parameters are shown in Table 
4. There was a significant positive correlation between 
Cd concentration in the serum and urine for the 
exposed workers (r = 0.362). Also, there was a 
significant positive correlation between the biological 
Cd exposure indices and serum calcium (r = 0.230, p 
< 0.05 with serum Cd, and r = 0.275, p < 0.05 with the 
urinary Cd). While there was a significant negative 
correlation between the Cd exposure indices and 
plasma PTH levels (r = -0.412, p < 0.01 with the 
serum Cd, and r = -0.478, p < 0.01 with the urinary 
Cd. 
 
 
Discussion  
 
In the current study, workers were exposed to 
poor workplace environment which is considered 
about 4 folds compared to Occupational Health and 
Safety Administration [17] permissible exposure limit 
(PEL) 5 μg/m
3
. Moreover, the workers in the present 
study didn’t use personal protective devices provided 
by the occupational safety department in the factory. 
This may have contributed to their high serum and 
urinary Cd levels. 
U-Cd level assesses long-term exposure to 
cadmium because it reflects the cadmium 
accumulation in the kidney; however current exposure 
is assessed by Cd level in blood [18]. In our study, as 
expected, the serum and urinary Cd concentrations of 
the exposed group were much higher than those of 
the non-exposed group as shown in Table 1. These 
results agreed with some previous studies who found 
significant higher urinary Cd concentrations among 
the workers compared to the controls [19-21]. Also, 
our results were in accordance with another study
 
who 
found higher serum Cd concentration among the 
workers exposed to Cd compared to controls [22]. 
Other investigators [19, 23]
 
found a linear correlation 
between Cd concentration in serum and urine. The 
data is consistent with our finding where a significant 
positive correlation was found between the Cd 
concentrations in the serum and urine for the exposed 
group. 
The current study results revealed absence of 
renal dysfunction of the exposed group as serum 
levels of urea and creatinine are within the normal 
range on one side, which agreed with previous studies 
results [19, 22], on another side absence of renal 
dysfunction was confirmed by normal alkaline 
phosphatase level which was in accordance with 
another earlier study [24]. 
Cadmium is suggested to have a direct 
osteotoxic effect even in the absence of renal 
dysfunction as occupational exposure to cadmium is 
associated with lower body mineral density and a 
higher urinary calcium excretion [25]. 
 
Table 4: Correlation between biological Cadmium exposure indices and different studied parameters  
Variable  urea Cr Albumin PTH calcium Phosphorous ALP Mg Serum Cd Urine Cd 
SerumCd r 0.058 0.097 0.088 - 0.412
**
 0.230
*
 0.016 0.113 0.019 1.000 0.362
**
 
Urine Cd r 0.114 0.077 0.091 - 0.478
**
 0.275
*
 0.192 0.010 0.189 0.362
**
 1.000 
* Significant at the level of P < 0.05; ** Significant at the level of P < 0.01.   
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Alkaline phosphatase estimation assesses 
bone turnover in chronic kidney disease patients, 
especially with elevated PTH levels [24]. The present 
study showed normal alkaline phosphatase level in 
the exposed group suggesting the absence of renal or 
bone affection.  
In this study, there was a significant decrease 
in the mean values of plasma PTH, serum 
phosphorus, and magnesium while there was a 
significant increase in the mean value of serum 
calcium in the exposed group compared with the 
controls.  
PTH is the most important endocrine regulator 
of calcium and phosphorus concentration in the 
extracellular fluid. Once in the circulation, PTH binds 
to PTH receptors that are located throughout the 
body. Thus, disorders of PTH excess or insufficiency 
not only affect serum levels of calcium and 
phosphorus but also affect bone, cardiac, skin, 
neurologic and other systemic manifestations. PTH 
secretion occurs in response to hypocalcemia and 
hyperphosphatemia and is inhibited by severe 
hypomagnesemia [26]. 
 
A study done on male rats indicated that the 
critical Cd concentration for the parathyroids may be 
lower than that for the kidney. Damage to the parathy-
roids at low Cd concentration suggests that the 
damaging effect of Cd may be caused by its indirect 
rather than direct action [7].
 
Cadmium increased levels were associated 
with increased bone resorption and lower secretion of 
PTH, but not with markers of bone formation [4]. Thus, 
the lower levels of PTH are most likely a 
compensatory decrease in the increased skeletal 
release of calcium due to enhanced bone resorption. 
Phosphorus is important for the modulation of calcium 
mobilization from the bone and the regulation of 
plasma calcium. Increase in serum calcium is 
associated with a decrease in serum phosphorus and 
increased urinary phosphorus excretion and vice 
versa [27].  
Hypoalbuminemia is avoided in the current 
study as in the presence of hypoalbuminemia, total 
serum calcium may be underestimated [28].  
In all patients with hypercalcemia, the PTH 
level should be suppressed. Thus, interpretation of a 
PTH level must always be done in conjunction with a 
simultaneous calcium level. If a serum calcium level is 
11.5 mg/dl and the PTH is 50 pg/ml then there is an 
inappropriate circulating level of PTH since it should 
be suppressed. Thus, despite the PTH is in the 
normal range (usually 10–65 pg/ml), it is indicative of 
hyperparathyroidism. However, if the calcium level 
was 8.0 mg/dl this level of PTH would be normal [29], 
this might explain the hypercalcemia and low normal 
phosphorus found in the exposed group despite their 
apparently normal PTH serum level.  
Although age, blood urea, serum albumin, 
and the nutritional state may influence the PTH level 
[30],
 
lack of any significant change in the present 
study suggests that probably they do not contribute to 
the Cd-induced parathyroid effects.  
In the present study exposed workers showed 
lower Mg level compared to the controls, which 
agreed with a previous study who investigated 
occupational exposure to cadmium and its effect on 
elements in Nickel - Cadmium battery production 
workers [20]. Low blood Mg levels, thought to be a 
result of Cd exposure, could be explained by an 
increased Cd level in the gut. It is induced by 
mucociliary transfer by bile elimination or by excretion 
of Cd through the intestine walls which in turn may 
cause an inhibition of Mg absorption in gut thus 
leading to a decrease of blood Mg [31]. A recent study 
concluded that Cd uptake in human osteoblastic cells 
occurs, at least in part, through Ca- and Mg-inhibitable 
transport mechanisms [32]. 
As regards the prevalence of musculoskeletal 
complaints (Table 3), bone ache, joint pain and 
muscle strain were more prevalent among the 
exposed workers compared to the controls. This may 
be referred to hypercalcemia, hypomagnesemia and 
hypophosphatemia found in the exposed group.  
The negative correlation between the Cd 
exposure indices and plasma PTH levels confirm the 
relationship between the damaging Cd impact on the 
parathyroids and the intensity of exposure and body 
burden of Cd as confirmed by a previous study [7].
 
In conclusion, it is apparent from our study 
that Cd exposure may have an adverse effect on PTH 
level and serum human minerals. Even in the absence 
of renal dysfunction, prominent parathormone level 
together with hypercalcemia as well as low normal 
phosphorus are basically indicative of primary 
hyperparathyroidism.  
Occupational cadmium exposure health 
hazards can be lessened through individual caring 
equipment, fine sanitation practices, manage and 
diminution of cadmium emissions. Alternatively, Mg 
supplementation [33] has a useful function in lowering 
Cd body load and might be intended for preclusion 
and/or treatment. Further studies on a larger scale are 
recommended. 
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